Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine

被引：42
|
作者：
Koong, Lin Ru [1 ]
Chee, Wai Kitt [1 ]
Toh, Zhi Hong [1 ]
Ng, Xin Le [1 ]
Agrawal, Rupesh [1 ,2 ,3 ,4 ]
Ho, Su Ling [1 ]
机构：
[1] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore 308433, Singapore
[2] Lee Kong Chian Sch Med, Singapore, Singapore
[3] Singapore Eye Res Inst, Ocular Infect & AntiMicrobials, Singapore, Singapore
[4] Duke NUS Med Sch, Acad & Clin Programme, Ophthalmol & Visual Sci, Singapore, Singapore
来源：
OCULAR IMMUNOLOGY AND INFLAMMATION | 2021年 / 29卷 / 06期
关键词：
COVID-19; vaccine; VKH disease; PfizerBioNtech; vaccine side effects; exudative retinal detachment;
D O I：
10.1080/09273948.2021.1974492
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
A 54-year-old Chinese male with no previous ocular history presented to the ophthalmology department for the bilateral acute painless blurring of vision after receiving the 1st dose of COVID-19 mRNA vaccine (PFIZER-BioNTech/COMIRNATY). Clinical examination and imaging tests were consistent with Vogt-Koyanagi-Hara disease. The patient responded well with a high dose of intravenous methylprednisolone followed by a tapering dose of oral prednisolone.
引用
收藏
页码：1212 / 1215
页数：4
相关论文
共 50 条
  • [1] Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 Vaccine
    De Domingo, Begona
    Lopez, Miguel
    Lopez-Valladares, Maria
    Ortegon-Aguilar, Esperanza
    Sopena-Perez-Arguelles, Bernardo
    Gonzalez, Francisco
    CELLS, 2022, 11 (06)
  • [2] Vogt-Koyanagi-Harada Uveitis Following Covid-19 Vaccine
    Daldoul, M.
    Lakhoua, G.
    Zaiem, A.
    Kaabi, W.
    Daghfous, R.
    Aidli, S. E.
    DRUG SAFETY, 2022, 45 (10) : 1211 - 1212
  • [3] A COVID-19 perspective of Vogt-Koyanagi-Harada disease
    Majumder, Parthopratim Dutta
    Sadhu, Soumen
    Gonzalez-Lopez, Julio J.
    Mochizuki, Manabu
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (06) : 2587 - 2591
  • [4] Effect of the COVID-19 pandemic on Vogt-Koyanagi-Harada disease
    Muto, Tetsuya
    Sakamoto, Masaaki
    Kusuda, Shoichiro
    Haruyama, Yasuo
    Machida, Shigeki
    Imaizumi, Shinichiro
    Sekiryu, Tetsuju
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [5] Vogt-Koyanagi-Harada Disease after COVID-19 Vaccination
    Lee, Chae Eun
    Kim, Sangah
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2023, 64 (10): : 976 - 980
  • [6] Vogt-Koyanagi-Harada Disease Following COVID-19 Infection
    Yepez, Juan B.
    Murati, Felipe A.
    Petitto, Michele
    De Yepez, Jazmin
    Galue, Jose M.
    Revilla, Julio
    Petitto, Alfonso
    Vinardell, Susana
    Arevalo, J. Fernando
    CASE REPORTS IN OPHTHALMOLOGY, 2021, 12 (03): : 804 - 808
  • [7] Clinical features, diagnosis, and management of COVID-19 vaccine-associated Vogt-Koyanagi-Harada disease
    Xu, Ke
    Gao, Bingqian
    Li, Jiayi
    Xiang, Yixin
    Cao, Lin
    Zhao, Mingyi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [8] Vogt-Koyanagi-Harada Disease and COVID
    Manni, Priscilla
    Saturno, Maria Carmela
    Accorinti, Massimo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [9] Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination
    Joo, Chan Woong
    Kim, Yong-Kyu
    Park, Sung Pyo
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (05) : 1250 - 1254
  • [10] Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination
    Accorinti, Massimo
    Saturno, Maria Carmela
    Manni, Priscilla
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (05) : 1228 - 1233
12345